ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
Dow Jones
44,546.08
-0.37%
US Dollar vs MXN
20.2736
-0.16%
Brent Oil
75.075
1.13%
Bitcoin
95,621.93
-0.53%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Sonnet BioTherapeutics Holdings Inc (SONN) Cotización

Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

NASDAQ
1.59
0.05
(3.25%)
Cerrado 17 Febrero 3:00PM
Delayed by 15 minutes
1.5997
0.0097
(0.61%)
Fuera de horario: 6:55PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.5997
Postura de Compra
1.56
Postura de Venta
1.60
Volume Operado de la Acción
47,532
1.54 Rango del Día 1.5999
1.41 Rango de 52 semanas 18.7192
Capitalización de Mercado [m]
4.904M
Precio Anterior
1.54
Precio de Apertura
1.57
Hora
2
@
1.5513
Última hora de negociación
Volumen financiero
US$ 74,664
Precio Promedio Ponderado
1.5708
Volumen promedio (3 m)
1,135,446
Acciones en circulación
3,065,701
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.64
Beneficio por acción (BPA)
-2.43
turnover
19k
Beneficio neto
-7.44M

Acerca de Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Management Consulting Svcs
Sitio web
www.sonnetbio.com
Sede
Wilmington, Delaware, USA
Fundado
2020
Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$1.54. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.41 to US$ 18.7192.

Sonnet BioTherapeutics currently has 3,065,701 shares in issue. The market capitalisation of Sonnet BioTherapeutics is US$4.72 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.64.

SONN Últimas noticias

Más noticias

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Febrero 2025
SONN (3.25%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Febrero 2025
SONN (3.25%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 Febrero 2025
SONN (3.25%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 Febrero 2025
SONN (3.25%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
31 Enero 2025
SONN (3.25%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
31 Enero 2025
SONN (3.25%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0003-0.018751.61.65671.5587191.57067965CS
40.04973.20645161291.552.051.441613031.78382325CS
12-1.2803-44.45486111112.884.851.4111354461.94849294CS
26-4.0403-71.63652482275.6410.021.417685022.76160408CS
52-10.4803-86.757450331112.0818.71921.414256553.7072835CS
156-729.4691-99.7811833852731.06881649.40161.411897775550.10815282CS
260-15324.4803-99.989562236415326.0839916.81.4122678892543.64668199CS

SONN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Sonnet BioTherapeutics?
El precio actual de las acciones de Sonnet BioTherapeutics es US$ 1.5997
¿Cuántas acciones de Sonnet BioTherapeutics están en circulación?
Sonnet BioTherapeutics tiene 3,065,701 acciones en circulación
¿Cuál es la capitalización de mercado de Sonnet BioTherapeutics?
La capitalización de mercado de Sonnet BioTherapeutics es USD 4.72M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Sonnet BioTherapeutics?
Sonnet BioTherapeutics ha negociado en un rango de US$ 1.41 a US$ 18.7192 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Sonnet BioTherapeutics?
El ratio precio/beneficio de Sonnet BioTherapeutics es -0.64
¿Cuál es el ratio de efectivo a ventas de Sonnet BioTherapeutics?
El ratio de efectivo a ventas de Sonnet BioTherapeutics es 250
¿Cuál es la moneda de reporte de Sonnet BioTherapeutics?
Sonnet BioTherapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Sonnet BioTherapeutics?
El último ingresos anual de Sonnet BioTherapeutics es USD 19k
¿Cuál es el último beneficio anual de Sonnet BioTherapeutics?
El último beneficio anual de Sonnet BioTherapeutics es USD -7.44M
¿Cuál es la dirección registrada de Sonnet BioTherapeutics?
La dirección registrada de Sonnet BioTherapeutics es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Sonnet BioTherapeutics?
La dirección del sitio web de Sonnet BioTherapeutics es www.sonnetbio.com
¿En qué sector industrial opera Sonnet BioTherapeutics?
Sonnet BioTherapeutics opera en el sector MANAGEMENT CONSULTING SVCS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
US$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
194.99M

SONN Discussion

Ver más
tw0122 tw0122 2 meses hace
Cash out time 5.45 + 150%
👍 1
LowFloatLopes LowFloatLopes 2 meses hace
I'm at $2.50 out at $4.50 in less than 8 mins lol 
👍️0
tw0122 tw0122 2 meses hace
Don't stay in long this one hardly ever stays up high long 3.49 +'80%
👍️0
Monksdream Monksdream 2 meses hace
SONN, 10Q due DEC 13
👍️0
tw0122 tw0122 3 meses hace
Reverse split was September 
👍️0
Invest-in-America Invest-in-America 3 meses hace
SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
👍️0
Tiger Money Tiger Money 3 meses hace
What is going on here?  Reverse?  Where is the float on this train wreck now?
👍️0
bigfart bigfart 3 meses hace
So insiders can dump before the RS
👍️0
tw0122 tw0122 3 meses hace
Reverse split offering and now some news $8s
👍️0
tw0122 tw0122 5 meses hace
May the reverse split gods come soon. Keep an eye!
👍️0
BooDog BooDog 5 meses hace
Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
👍️0
Clemdane Clemdane 5 meses hace
Big jump today!
👍️0
Awl416 Awl416 6 meses hace
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
👍️ 1
Monksdream Monksdream 6 meses hace
SONN new 52=low
👍️0
Clemdane Clemdane 6 meses hace
Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
👍️0
Monksdream Monksdream 6 meses hace
SONN new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
SONN new 52 week low
👍️0
Monksdream Monksdream 8 meses hace
SONN new 52 week low
👍️0
Monksdream Monksdream 8 meses hace
SONN new 52 week low
👍️0
BooDog BooDog 10 meses hace
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
👍️0
maq1214 maq1214 11 meses hace
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
👍️0
81vette 81vette 11 meses hace
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
👍️0
81vette 81vette 11 meses hace
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
👍️0
maq1214 maq1214 11 meses hace
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
👍️0
81vette 81vette 11 meses hace
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
👍️0
81vette 81vette 11 meses hace
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
👍️0
81vette 81vette 11 meses hace
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
👍️0
BooDog BooDog 11 meses hace
Riding free again.
👍️0
Monksdream Monksdream 12 meses hace
SONN under $2
👍️0
crowin crowin 1 año hace
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
👍️0
maq1214 maq1214 1 año hace
This should get exciting soon, crazy volume yesterday !
👍️0
BooDog BooDog 1 año hace
IS it just greed or might this make good for another round trip? We'll see next week.
👍️0
BooDog BooDog 1 año hace
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
BooDog BooDog 1 año hace
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
👍️0
valleybenedetto valleybenedetto 1 año hace
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
valleybenedetto valleybenedetto 1 año hace
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
👍️0
Monksdream Monksdream 1 año hace
If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
👍️0
valleybenedetto valleybenedetto 1 año hace
You worry about you ok?
👍️0
Monksdream Monksdream 1 año hace
You aren’t getting any money back
Time to move on
👍️0
valleybenedetto valleybenedetto 1 año hace
Not an Urban Myth ..I've already checked. They have current D and O insurance.
👍️0
Monksdream Monksdream 1 año hace
Oh goddamn tell me another urban myth
👍️0
valleybenedetto valleybenedetto 1 año hace
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
👍️0
Monksdream Monksdream 1 año hace
You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
👍️0
valleybenedetto valleybenedetto 1 año hace
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0

Su Consulta Reciente

NASDAQ
SONN
Sonnet BioTherapeutics
NYSE
MSDL
Morgan Stanley Direct Le...
NASDAQ
OMAB
Grupo Aeroportuario del ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios